URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Mahlon Johnson

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentPathology and Laboratory Medicine
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester NY 14642
Other Positions
TitleDirector, Neuropathology
InstitutionSchool of Medicine and Dentistry
DepartmentPathology and Laboratory Medicine

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentNeurosurgery

 
 Awards And Honors
1976     Phi Kappa Phi
1980     Alpha Omega Alpha Medical Honor Society
1982 - 1984NIH National Research Service Award
1984     Sigma Xi Excellence in Research Award
2001     Pathology Residents Teaching Award, Anatomic Pathology
 
 Overview
Dr. Johnson's primary research interest is in the growth regulation of the leptomeninges and meningiomas.

 
 Selected Publications
List All   |   Timeline
  1. Johnson MD, O'Connell MJ, Silberstein H, Korones D. Differential Expression of Somatostatin Receptors, P44/42 MAPK, and mTOR Activation in Medulloblastomas and Primitive Neuroectodermal Tumors. Appl Immunohistochem Mol Morphol. 2013 Dec; 21(6):532-8.
    View in: PubMed
  2. Johnson MD, O'Connell MJ, Walter K. Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis. BMC Complement Altern Med. 2013; 13(1):303.
    View in: PubMed
  3. Johnson M, Mazariegos J, Lewis PJ, Pomakova D. Crystal storing histiocytosis presenting as a temporal lobe mass lesion. Surg Neurol Int. 2013; 4:112.
    View in: PubMed
  4. Auvergne RM, Sim FJ, Wang S, Chandler-Militello D, Burch J, Al Fanek Y, Davis D, Benraiss A, Walter K, Achanta P, Johnson M, Quinones-Hinojosa A, Natesan S, Ford HL, Goldman SA. Transcriptional Differences between Normal and Glioma-Derived Glial Progenitor Cells Identify a Core Set of Dysregulated Genes. Cell Rep. 2013 Jun 27; 3(6):2127-41.
    View in: PubMed
  5. Johnson MD, O'Connell M. Na-K-2Cl cotransporter and aquaporin 1 in arachnoid granulations, meningiomas, and meningiomas invading dura. Hum Pathol. 2013 Jun; 44(6):1118-24.
    View in: PubMed
  6. Johnson MD, Piech K, Emandian S. Radiation-associated meningioma in the elderly: development of meningioma with olfactory neuroblastoma recurrence 10 years after irradiation. Ann Clin Lab Sci. 2013; 43(4):460-3.
    View in: PubMed
  7. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol. 2013 May; 23(3):303-10.
    View in: PubMed
  8. Somers KE, Almast J, Biemiller RA, Silberstein HJ, Johnson MD, Mohile NA. Diagnosis of primary CNS melanoma with neuroimaging. J Clin Oncol. 2013 Jan 1; 31(1):e9-e11.
    View in: PubMed
  9. Johnson MD, O'Connell M, Iqbal MA, Williams JP. Radiation effects on human leptomeningeal cell response to cerebrospinal fluid and PDGF-BB. Int J Radiat Biol. 2012 Jul; 88(7):547-55.
    View in: PubMed
  10. Powers JM, Johnson MD. Mycoplasmal panencephalitis: a neuropathologic documentation. Acta Neuropathol. 2012 Jul; 124(1):143-8.
    View in: PubMed
  11. Johnson MD, O'Connell M, Facik M, Maurer P, Jahromi B, Pilcher W. Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3. J Neurooncol. 2012 Mar; 107(1):121-31.
    View in: PubMed
  12. Liu X, Tian W, Kolar B, Yeaney GA, Qiu X, Johnson MD, Ekholm S. MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas. Neuro Oncol. 2011 Apr; 13(4):447-55.
    View in: PubMed
  13. Lin WC, Sandberg DI, Bhatia S, Johnson M, Oh S, Ragheb J. Diffuse reflectance spectroscopy for in vivo pediatric brain tumor detection. J Biomed Opt. 2010 Nov-Dec; 15(6):061709.
    View in: PubMed
  14. Johnson MD, Shaw AK, O'Connell MJ, Sim FJ, Moses HL. Analysis of transforming growth factor ß receptor expression and signaling in higher grade meningiomas. J Neurooncol. 2011 Jun; 103(2):277-85.
    View in: PubMed
  15. Johnson MD, O'Connell M, Pilcher W. Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism. J Neurooncol. 2011 Feb; 101(3):441-8.
    View in: PubMed
  16. Johnson MD, O'Connell MJ, Pilcher W, Reeder JE. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway. J Neurosurg. 2010 May; 112(5):934-9.
    View in: PubMed
  17. Johnson MD, Vito F, Xu H, Xu H. MUC16 expression and risk of adenocarcinoma metastases to peritoneum, pleura, leptomeninges, and brain. Appl Immunohistochem Mol Morphol. 2010 May; 18(3):250-3.
    View in: PubMed
  18. Liu Y, Carson-Walter EB, Cooper A, Winans BN, Johnson MD, Walter KA. Vascular gene expression patterns are conserved in primary and metastatic brain tumors. J Neurooncol. 2010 Aug; 99(1):13-24.
    View in: PubMed
  19. Carson-Walter EB, Winans BN, Whiteman MC, Liu Y, Jarvela S, Haapasalo H, Tyler BM, Huso DL, Johnson MD, Walter KA. Characterization of TEM1/endosialin in human and murine brain tumors. BMC Cancer. 2009; 9:417.
    View in: PubMed
  20. Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA. Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study. J Neurooncol. 2010 May; 98(1):83-92.
    View in: PubMed
  21. Johnson MD, O'Connell MJ, Vito F, Pilcher W. Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. J Neuropathol Exp Neurol. 2009 Nov; 68(11):1177-83.
    View in: PubMed
  22. Aoki M, Matsuda T, Tomo Y, Miyata Y, Inoue M, Kigawa T, Yokoyama S. Automated system for high-throughput protein production using the dialysis cell-free method. Protein Expr Purif. 2009 Dec; 68(2):128-36.
    View in: PubMed
  23. Lin WC, Sandberg DI, Bhatia S, Johnson M, Morrison G, Ragheb J. Optical spectroscopy for in-vitro differentiation of pediatric neoplastic and epileptogenic brain lesions. J Biomed Opt. 2009 Jan-Feb; 14(1):014028.
    View in: PubMed
  24. Johnson MD, Moots PL, Zhuang Z, Weil RJ. Molecular genetic analysis of a primitive neuroectodermal tumor arising after intracranial radiation and chemotherapy for leukemia. Ann Clin Lab Sci. 2009; 39(3):295-302.
    View in: PubMed
  25. Johnson MD, O'Connell M, Vito F, Bakos RS. Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas. J Neurooncol. 2009 Apr; 92(2):129-36.
    View in: PubMed
  26. Bhatia S, Ragheb J, Johnson M, Oh S, Sandberg DI, Lin WC. The role of optical spectroscopy in epilepsy surgery in children. Neurosurg Focus. 2008 Sep; 25(3):E24.
    View in: PubMed
  27. Mentrikoski M, Johnson MD, Korones DN, Scott GA. Glioblastoma multiforme in skin: a report of 2 cases and review of the literature. Am J Dermatopathol. 2008 Aug; 30(4):381-4.
    View in: PubMed
  28. Johnson MD, Vito F, O'Connell MJ. Mesothelin expression in the leptomeninges and meningiomas. J Histochem Cytochem. 2008 Jun; 56(6):579-85.
    View in: PubMed
  29. Johnson MD, Fan X, Bourne P, Walters D. Neuronal differentiation and expression of neural epitopes in pituitary adenomas. J Histochem Cytochem. 2007 Dec; 55(12):1265-71.
    View in: PubMed
  30. Johnson MD, Sade B, Milano MT, Lee JH, Toms SA. New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J Neurooncol. 2008 Jan; 86(1):109-22.
    View in: PubMed
  31. Toms SA, Lin WC, Weil RJ, Johnson MD, Jansen ED, Mahadevan-Jansen A. Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity. Neurosurgery. 2007 Jul; 61(1 Suppl):327-35; discussion 335-6.
    View in: PubMed
  32. Majumder SK, Gebhart S, Johnson MD, Thompson R, Lin WC, Mahadevan-Jansen A. A probability-based spectroscopic diagnostic algorithm for simultaneous discrimination of brain tumor and tumor margins from normal brain tissue. Appl Spectrosc. 2007 May; 61(5):548-57.
    View in: PubMed
  33. Johnson MD, Stevenson CB, Thompson RC, Atkinson J, Boyer P. December 2006: 31-year-old woman with hemiparesis. Brain Pathol. 2007 Apr; 17(2):255-7.
    View in: PubMed
  34. Johnson MD, Floyd JL, Caprioli RM. Proteomics in diagnostic neuropathology. J Neuropathol Exp Neurol. 2006 Sep; 65(9):837-45.
    View in: PubMed
  35. Johnson M, Pace J, Burroughs JF. Fourth ventricle rosette-forming glioneuronal tumor. Case report. J Neurosurg. 2006 Jul; 105(1):129-31.
    View in: PubMed
  36. Mangels KJ, Johnson MD, Weil RJ. 35-year-old woman with progressive bilateral leg weakness. Brain Pathol. 2006 Apr; 16(2):183-4, 187.
    View in: PubMed
  37. Desai J, Shannon ME, Johnson MD, Ruff DW, Hughes LA, Kerley MK, Carpenter DA, Johnson DK, Rinchik EM, Culiat CT. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum Mol Genet. 2006 Apr 15; 15(8):1329-41.
    View in: PubMed
  38. Johnson M, Toms S. Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy? J Neuropathol Exp Neurol. 2005 Dec; 64(12):1029-36.
    View in: PubMed
  39. Stevenson CB, Johnson MD, Thompson RC. Cystic cavernous malformation of the cerebellopontine angle. Case illustration. J Neurosurg. 2005 Nov; 103(5):931.
    View in: PubMed
  40. Toms SA, Lin WC, Weil RJ, Johnson MD, Jansen ED, Mahadevan-Jansen A. Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity. Neurosurgery. 2005 Oct; 57(4 Suppl):382-91; discussion 382-91.
    View in: PubMed
  41. Schwartz SA, Weil RJ, Thompson RC, Shyr Y, Moore JH, Toms SA, Johnson MD, Caprioli RM. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res. 2005 Sep 1; 65(17):7674-81.
    View in: PubMed
  42. Aharon AS, Mulloy MR, Drinkwater DC, Lao OB, Johnson MD, Thunder M, Yu C, Chang P. Cerebral activation of mitogen-activated protein kinases after circulatory arrest and low flow cardiopulmonary bypass. Eur J Cardiothorac Surg. 2004 Nov; 26(5):912-9.
    View in: PubMed
  43. Uschuplich V, Mileusnic D, Johnson M. Pathologic quiz case. Progressive fatal encephalopathy in an immunosuppressed patient with a history of discoid lupus erythematosus. Subacute granulomatous meningoencephalitis (Acanthamoeba culbertsoni). Arch Pathol Lab Med. 2004 Sep; 128(9):e109-11.
    View in: PubMed
  44. Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Pediatr Blood Cancer. 2004 Jul; 43(1):46-54.
    View in: PubMed
  45. Zhuang Z, Lee YS, Zeng W, Furuta M, Valyi-Nagy T, Johnson MD, Vnencak-Jones CL, Woltjer RL, Weil RJ. Molecular genetic and proteomic analysis of synchronous malignant gliomas. Neurology. 2004 Jun 22; 62(12):2316-9.
    View in: PubMed
  46. Johnson MD, Mitchell AR, Troup EC, Bhowmick DA, Wait SD, Aulino J, Zhuang Z, Weil RJ. Congenital cystic hemangioblastomas of the cerebral hemisphere in a neonate without alteration in the VHL gene. Pediatr Neurosurg. 2004 May-Jun; 40(3):124-7.
    View in: PubMed
  47. Cho DG, Mulloy MR, Chang PA, Johnson MD, Aharon AS, Robison TA, Buckles TL, Byrne DW, Drinkwater DC. Blockade of the extracellular signal-regulated kinase pathway by U0126 attenuates neuronal damage following circulatory arrest. J Thorac Cardiovasc Surg. 2004 Apr; 127(4):1033-40.
    View in: PubMed
  48. Schwartz SA, Weil RJ, Johnson MD, Toms SA, Caprioli RM. Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res. 2004 Feb 1; 10(3):981-7.
    View in: PubMed
  49. Johnson MD, Okediji E, Woodard A. Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways. J Neurooncol. 2004 Jan; 66(1-2):9-16.
    View in: PubMed
  50. Johnson MD, Aulino JP, Jagasia M, Mawn LA. Erdheim-chester disease mimicking multiple meningiomas syndrome. AJNR Am J Neuroradiol. 2004 Jan; 25(1):134-7.
    View in: PubMed
  51. Johnson MD, Kim P, Tourtellotte W, Federspiel CF. Transforming growth factor beta and monocyte chemotactic protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection. J NeuroAIDS. 2004; 2(4):33-43.
    View in: PubMed
  52. Johnson MD, Vnencak-Jones CL, Toms SA, Moots PM, Weil R. Allelic losses in oligodendroglial and oligodendroglioma-like neoplasms: analysis using microsatellite repeats and polymerase chain reaction. Arch Pathol Lab Med. 2003 Dec; 127(12):1573-9.
    View in: PubMed
  53. Woltjer RL, Weil RJ, Moots PL, Johnson MD. Pathologic quiz case: cerebellar hemorrhage in an octogenarian. Gliosarcoma. Arch Pathol Lab Med. 2003 Aug; 127(8):e345-6.
    View in: PubMed
  54. Johnson M. Maria. An unexpected meeting between a doctor and a girl with AIDS bears fruit for HIV prevention efforts. Health Aff (Millwood). 2003 Jul-Aug; 22(4):179-83.
    View in: PubMed
  55. Fan X, Semchyshyn TM, Mawn LA, Atkinson JB, Anderson JC, Toms SA, Johnson MD. July 2002: 66-year-old female with a one-year history of progressive left proptosis. Brain Pathol. 2003 Jan; 13(1):111-2, 117.
    View in: PubMed
  56. Johnson MD, Powell SZ, Boyer PJ, Weil RJ, Moots PL. Dural lesions mimicking meningiomas. Hum Pathol. 2002 Dec; 33(12):1211-26.
    View in: PubMed
  57. Fan X, Olson SJ, Blevins LS, Allen GS, Johnson MD. Immunohistochemical localization of carboxypeptidases D, E, and Z in pituitary adenomas and normal human pituitary. J Histochem Cytochem. 2002 Nov; 50(11):1509-16.
    View in: PubMed
  58. Johnson MD, Okedli E, Woodard A, Toms SA, Allen GS. Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells. J Neurosurg. 2002 Sep; 97(3):668-75.
    View in: PubMed
  59. Paueksakon P, Parker JR, Fan X, Miles G, Ruiz H, Wushensky C, Johnson MD. Melanotic neuroectodermal tumor of infancy discovered after head trauma. Pediatr Neurosurg. 2002 Jan; 36(1):33-6.
    View in: PubMed
  60. Schefter JK, Allen G, Cmelak AJ, Johnson M, Toms S, Duggan D, Blevins LS. The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas. J Neurooncol. 2002 Jan; 56(1):69-78.
    View in: PubMed
  61. Johnson MD, Woodard A, Okediji EJ, Toms SA, Allen GS. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. J Neurooncol. 2002 Jan; 56(2):133-42.
    View in: PubMed
  62. Weil RJ, Toms SA, Johnson MD, Mealer A. Detection of proliferating S-phase brain tumor cells by in situ DNA replication. J Neurosurg. 2001 Nov; 95(5):833-8.
    View in: PubMed
  63. Fan X, Turner JE, Turner TM, Elrod JP, Clough JA, Howell EI, Johnson MD. Carcinoid tumor development in an intramedullary spinal cord mature teratoma. AJNR Am J Neuroradiol. 2001 Oct; 22(9):1778-81.
    View in: PubMed
  64. Fan X, Olson SJ, Johnson MD. Immunohistochemical localization and comparison of carboxypeptidases D, E, and Z, alpha-MSH, ACTH, and MIB-1 between human anterior and corticotroph cell "basophil invasion" of the posterior pituitary. J Histochem Cytochem. 2001 Jun; 49(6):783-90.
    View in: PubMed
  65. Johnson MD, Jennings MT, Toms ST. Oligodendroglial ganglioglioma with anaplastic features arising from the thalamus. Pediatr Neurosurg. 2001 Jun; 34(6):301-5.
    View in: PubMed
  66. Fan X, Larson TC, Jennings MT, Tulipan NB, Toms SA, Johnson MD. December 2000: 6 month old boy with 2 week history of progressive lethargy. Brain Pathol. 2001 Apr; 11(2):265-6.
    View in: PubMed
  67. Lin WC, Toms SA, Johnson M, Jansen ED, Mahadevan-Jansen A. In vivo brain tumor demarcation using optical spectroscopy. Photochem Photobiol. 2001 Apr; 73(4):396-402.
    View in: PubMed
  68. Johnson MD, Woodard A, Kim P, Frexes-Steed M. Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells. J Neurosurg. 2001 Feb; 94(2):293-300.
    View in: PubMed
  69. Johnson MD, Kinney MC, Scheithauer BW, Briley RJ, Hamilton K, McPherson WF, Barton JH. Primary intracerebral Hodgkin's disease mimicking meningioma: case report. Neurosurgery. 2000 Aug; 47(2):454-6; discussion 456-7.
    View in: PubMed
  70. Singer RJ, Clough J, Johnson M, Atkinson JB, Copeland M. Pigmented schwannoma of the ventral spinal cord. South Med J. 1999 May; 92(5):532-4.
    View in: PubMed
  71. Johnson MD, Vnencak-Jones CL, McLean MJ. Fatal familial insomnia: clinical and pathologic heterogeneity in genetic half brothers. Neurology. 1998 Dec; 51(6):1715-7.
    View in: PubMed
  72. Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol. 1997 Oct 20; 139(2):541-52.
    View in: PubMed
  73. Johnson MD, Schaffner W, Atkinson J, Pierce MA. Autopsy risk and acquisition of human immunodeficiency virus infection: a case report and reappraisal. Arch Pathol Lab Med. 1997 Jan; 121(1):64-6.
    View in: PubMed
  74. Johnson MD, Gold LI. Distribution of transforming growth factor-beta isoforms in human immunodeficiency virus-1 encephalitis. Hum Pathol. 1996 Jul; 27(7):643-9.
    View in: PubMed
  75. Johnson MD, Creasy JL. Radiologic and laboratory evaluation of enhancing brain lesions in patients with AIDS. Compr Ther. 1995 Nov; 21(11):645-52.
    View in: PubMed
  76. Pierce MA, Johnson MD, Maciunas RJ, Murray MJ, Allen GS, Harbison MA, Creasy JL, Kessler RM. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med. 1995 Oct 15; 123(8):594-8.
    View in: PubMed
  77. Johnson MD, Jennings MT, Lavin P, Creasy JL, Maciunas RJ. Ganglioglioma of the pineal gland: clinical and radiographic response to stereotactic radiosurgical ablation. J Child Neurol. 1995 May; 10(3):247-9.
    View in: PubMed
  78. Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, Dettbarn WD. Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol. 1995 Jan; 10(1):37-45.
    View in: PubMed
  79. Johnson MD, Maciunas R, Creasy J, Collins RD. Indolent granulomatous angiitis. Case report. J Neurosurg. 1994 Sep; 81(3):472-6.
    View in: PubMed
  80. Johnson MD, Horiba M, Winnier AR, Arteaga CL. The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas. Hum Pathol. 1994 Feb; 25(2):146-53.
    View in: PubMed
  81. Pierce DF, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, Daniel CW, Hogan BL, Moses HL. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev. 1993 Dec; 7(12A):2308-17.
    View in: PubMed
  82. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. J Clin Invest. 1993 Dec; 92(6):2569-76.
    View in: PubMed
  83. Jennings MT, Slatkin N, D'Angelo M, Ketonen L, Johnson MD, Rosenblum M, Creasy J, Tulipan N, Walker R. Neoplastic meningitis as the presentation of occult primitive neuroectodermal tumors. J Child Neurol. 1993 Oct; 8(4):306-12.
    View in: PubMed
  84. Johnson MD, Jennings MT, Gold LI, Moses HL. Transforming growth factor-beta in neural embryogenesis and neoplasia. Hum Pathol. 1993 May; 24(5):457-62.
    View in: PubMed
  85. Bosque PJ, Vnencak-Jones CL, Johnson MD, Whitlock JA, McLean MJ. A PrP gene codon 178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt-Jakob disease. Neurology. 1992 Oct; 42(10):1864-70.
    View in: PubMed
  86. Johnson MD, Gold LI, Moses HL. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid. Lab Invest. 1992 Sep; 67(3):360-8.
    View in: PubMed
  87. Johnson MD, Federspiel CF, Gold LI, Moses HL. Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells. Am J Pathol. 1992 Sep; 141(3):633-42.
    View in: PubMed
  88. Jennings MT, Jennings DL, Ebrahim SA, Johnson MD, Turc-Carel C, Philip T, Philip I, Lapras C, Shapiro JR. In vitro karyotypic and immunophenotypic characterisation of primitive neuroectodermal tumours: similarities to malignant gliomas. Eur J Cancer. 1992; 28A(4-5):762-6.
    View in: PubMed
  89. Arteaga CL, Johnson MD, Todderud G, Coffey RJ, Carpenter G, Page DL. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A. 1991 Dec 1; 88(23):10435-9.
    View in: PubMed
  90. Pelton RW, Johnson MD, Perkett EA, Gold LI, Moses HL. Expression of transforming growth factor-beta 1, -beta 2, and -beta 3 mRNA and protein in the murine lung. Am J Respir Cell Mol Biol. 1991 Dec; 5(6):522-30.
    View in: PubMed
  91. Johnson MD, Gray ME, Pepinsky RB, Stahlman MT. Lipocortin-1 immunoreactivity in the human pituitary gland. J Histochem Cytochem. 1990 Dec; 38(12):1841-5.
    View in: PubMed
  92. Johnson MD, Lavin P, Whetsell WO. Fulminant monophasic multiple sclerosis, Marburg's type. J Neurol Neurosurg Psychiatry. 1990 Oct; 53(10):918-21.
    View in: PubMed
  93. Johnson MD, Gray ME, Carpenter G, Pepinsky RB, Stahlman MT. Ontogeny of epidermal growth factor receptor and lipocortin-1 in fetal and neonatal human lungs. Hum Pathol. 1990 Feb; 21(2):182-91.
    View in: PubMed
  94. Johnson MD, Kamso-Pratt J, Federspiel CF, Whetsell WO. Mast cell and lymphoreticular infiltrates in neurofibromas. Comparison with nerve sheath tumors. Arch Pathol Lab Med. 1989 Nov; 113(11):1263-70.
    View in: PubMed
  95. Johnson MD, Kamso-Pratt JM, Whetsell WO, Pepinsky RB. Lipocortin-1 immunoreactivity in the normal human central nervous system and lesions with astrocytosis. Am J Clin Pathol. 1989 Oct; 92(4):424-9.
    View in: PubMed
  96. Johnson MD, Kamso-Pratt J, Pepinsky RB, Whetsell WO. Lipocortin-1 immunoreactivity in central and peripheral nervous system glial tumors. Hum Pathol. 1989 Aug; 20(8):772-6.
    View in: PubMed
  97. Johnson MD, Gray ME, Carpenter G, Pepinsky RB, Sundell H, Stahlman MT. Ontogeny of epidermal growth factor receptor/kinase and of lipocortin-1 in the ovine lung. Pediatr Res. 1989 May; 25(5):535-41.
    View in: PubMed
  98. Johnson MD, Tulipan N, Whetsell WO. Osteoblastic meningioma of the fourth ventricle. Neurosurgery. 1989 Apr; 24(4):587-90.
    View in: PubMed
  99. Johnson MD, Davis BW, Wetherall NT. Production of proto-oncogene expressing control tissues for in situ hybridization and immunohistochemical studies. J Environ Pathol Toxicol Oncol. 1989 Mar-Apr; 9(2):171-90.
    View in: PubMed
  100. Johnson M, Maciunas R, Dutt P, Clinton ME, Collins R. Granulomatous angiitis masquerading as a mass lesion. Magnetic resonance imaging and stereotactic biopsy findings in a patient with occult Hodgkin's disease. Surg Neurol. 1989 Jan; 31(1):49-53.
    View in: PubMed
  101. Johnson MD, Glick AD, Whetsell WO. Central hypomyelination associated with congenital hypomyelinating polyneuropathy: report of an autopsied case. Clin Neuropathol. 1989 Jan-Feb; 8(1):28-34.
    View in: PubMed
  102. Johnson MD, Newman JH, Baxter JW. Neuroleptic malignant syndrome presenting as adult respiratory distress syndrome and disseminated intravascular coagulation. South Med J. 1988 Apr; 81(4):543-5.
    View in: PubMed
  103. Johnson MD, Glick AD, Davis BW. Immunohistochemical evaluation of Leu-7, myelin basic-protein, S100-protein, glial-fibrillary acidic-protein, and LN3 immunoreactivity in nerve sheath tumors and sarcomas. Arch Pathol Lab Med. 1988 Feb; 112(2):155-60.
    View in: PubMed
  104. Johnson MD, Gray ME, Stahlman MT. Calcitonin gene-related peptide in human fetal lung and in neonatal lung disease. J Histochem Cytochem. 1988 Feb; 36(2):199-204.
    View in: PubMed
  105. Johnson MD, Crowley WR. Role of central serotonin systems in the stimulatory effects of ovarian hormones and naloxone on luteinizing hormone release in female rats. Endocrinology. 1986 Mar; 118(3):1180-6.
    View in: PubMed
  106. Johnson MD, Whetsell WO, Crowley WR. Quinolinic acid stimulates luteinizing hormone secretion in female rats: evidence for involvement of N-methyl-D-aspartate-preferring receptors. Exp Brain Res. 1985; 59(1):57-61.
    View in: PubMed
  107. Johnson MD, Carroll BL, Whetsell WO, Crowley WR. Quinolinic acid stimulates luteinizing hormone secretion through a serotonin-dependent mechanism. Exp Brain Res. 1985; 59(1):62-7.
    View in: PubMed
  108. Lynch CO, Johnson MD, Crowley WR. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions. Life Sci. 1984 Oct 1; 35(14):1481-7.
    View in: PubMed
  109. Johnson MD, Crowley WR. Effects of opiate antagonists on serotonin turnover and on luteinizing hormone and prolactin secretion in estrogen- or morphine-treated rats. Neuroendocrinology. 1984 Apr; 38(4):322-7.
    View in: PubMed
  110. Johnson MD, Crowley WR. Acute effects of estradiol on circulating luteinizing hormone and prolactin concentrations and on serotonin turnover in individual brain nuclei. Endocrinology. 1983 Dec; 113(6):1935-41.
    View in: PubMed
  111. Adler BA, Johnson MD, Lynch CO, Crowley WR. Evidence that norepinephrine and epinephrine systems mediate the stimulatory effects of ovarian hormones on luteinizing hormone and luteinizing hormone-releasing hormone. Endocrinology. 1983 Oct; 113(4):1431-8.
    View in: PubMed
  112. Johnson MD, Crowley WR. Serotonin turnover in individual brain nuclei: evaluation of three methods using liquid chromatography with electrochemical detection. Life Sci. 1982 Aug 9; 31(6):589-95.
    View in: PubMed
  113. Terry LC, Crowley WR, Lynch C, Longserre C, Johnson MD. Role of central epinephrine in regulation of anterior pituitary hormone secretion. Peptides. 1982 May-Jun; 3(3):311-8.
    View in: PubMed
  114. Crowley WR, Terry LC, Johnson MD. Evidence for the involvement of central epinephrine systems in the regulation of luteinizing hormone, prolactin, and growth hormone release in female rats. Endocrinology. 1982 Apr; 110(4):1102-7.
    View in: PubMed
  115. Terry LC, Crowley WR, Johnson MD. Regulation of episodic growth hormone secretion by the central epinephrine system. Studies in the chronically cannulated rat. J Clin Invest. 1982 Jan; 69(1):104-12.
    View in: PubMed

Visualizations


Johnson's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department